Literature DB >> 16476600

Totally percutaneous aortic aneurysm repair: experience and prudence.

Benjamin Ware Starnes1, Charles A Andersen, Joseph A Ronsivalle, Neal R Stockmaster, Philip S Mullenix, John D Statler.   

Abstract

OBJECTIVE: Totally percutaneous aortic aneurysm repair has been shown to be technically feasible, with low morbidity. Complications from percutaneous arterial closure are not insignificant, however, and can be fatal. We sought to evaluate our experience with this technique, compare it with the published literature, and identify factors associated with conversion to open repair and complications.
METHODS: A retrospective review of a prospectively collected database was performed. All patients who underwent percutaneous closure of large-bore-sheath (>12F) access sites with off-label use of a suture-mediated closure device (Prostar XL) between December 2002 and August 2005 were reviewed. Outcome measures evaluated were rates of technical success, conversion to open femoral arterial repair, and complications. Axial diameter measurements of the accessed vessels were assessed with computed tomographic (CT) angiography both before and after the procedure. Patient variables were compared by using chi2, Fisher exact, and paired and independent samples t tests where appropriate. The mean follow-up interval was 1.5 years.
RESULTS: During the study period, 49 patients underwent percutaneous closure of 79 large-bore-sheath access sites after successful endovascular aneurysm repair. Seven patients (14%) were morbidly obese (body mass index >35 kg/m2). Successful closure was achieved in 74 access sites (93.7%). Percutaneous closure was unsuccessful in five access sites (6.3%), all of which required open femoral repair at the same setting. Two converted patients experienced complications (4.1%): one retroperitoneal hematoma requiring transfusion of blood products and one iliac artery injury leading to death from myocardial infarction. Both of these patients were morbidly obese. Both complications occurred after closure of larger than 20F sheath sites. Morbid obesity and sheath size greater than 20F were associated with a significantly increased complication rate (P = .02 and P = .01, respectively). No thrombotic or infectious complications occurred in this series. Upon comparison of preoperative and postoperative CT angiograms, one (1.3%) small pseudoaneurysm was detected. No arteriovenous fistulas or hematomas larger than 3 cm were detected. The pseudoaneurysm occurred after closure of a 20F sheath access site. There were no significant differences in minimum intraluminal (7.38 +/- 1.8 vs 7.48 +/- 1.8) or maximum extraluminal (11.25 +/- 2.8 vs 12.02 +/- 2.7) diameters between preoperative and postoperative CT angiograms, respectively.
CONCLUSIONS: Totally percutaneous aortic aneurysm repair is technically feasible in most cases, with no effect on the luminal diameter of the accessed femoral artery. Complications occur more often in morbidly obese patients and with sheaths larger than 20F. These complications can be minimized with meticulous technique and good patient selection. The capability for expeditious open femoral arterial repair is mandatory with this approach.

Entities:  

Mesh:

Year:  2006        PMID: 16476600     DOI: 10.1016/j.jvs.2005.11.004

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

1.  Ultrasound-guided percutaneous endovascular aneurysm repair success is predicted by access vessel diameter.

Authors:  Rodney P Bensley; Rob Hurks; Zhen Huang; Frank Pomposelli; Allen Hamdan; Mark Wyers; Elliot Chaikof; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2012-02-22       Impact factor: 4.268

2.  Percutaneous thoracic endovascular aortic repair is not contraindicated in obese patients.

Authors:  Jason Zakko; Salvatore Scali; Adam W Beck; Charles T Klodell; Thomas M Beaver; Tomas D Martin; Thomas S Huber; Robert J Feezor
Journal:  J Vasc Surg       Date:  2014-05-17       Impact factor: 4.268

3.  A single-centre experience of 200 consecutive unselected patients in percutaneous EVAR.

Authors:  Sergio Petronelli; Maria Teresa Zurlo; Silvia Giambersio; Lucia Danieli; Mariaelena Occhipinti
Journal:  Radiol Med       Date:  2014-04-04       Impact factor: 3.469

4.  Percutaneous versus femoral cutdown access for endovascular aneurysm repair.

Authors:  Dominique B Buck; Eleonora G Karthaus; Peter A Soden; Klaas H J Ultee; Joost A van Herwaarden; Frans L Moll; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2015-03-28       Impact factor: 4.268

5.  The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007.

Authors:  Kristina A Giles; Mark C Wyers; Frank B Pomposelli; Allen D Hamdan; Y Avery Ching; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2010-09-16       Impact factor: 4.268

6.  Canadian experience with percutaneous endovascular aneurysm repair: short-term outcomes.

Authors:  S Marlene Grenon; Joel Gagnon; York N Hsiang; Jerry C Chen
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

7.  Total percutaneous femoral vessels cannulation for minimally invasive mitral valve surgery.

Authors:  Matteo Pozzi; Roland Henaine; Daniel Grinberg; Jacques Robin; Christine Saroul; Bertrand Delannoy; Olivier Desebbe; Jean-François Obadia
Journal:  Ann Cardiothorac Surg       Date:  2013-11

Review 8.  Fascia Suture Technique and Suture-mediated Closure Devices: Systematic Review.

Authors:  Georgios Karaolanis; Ioannis D Kostakis; Demetrios Moris; Viktoria-Varvara Palla; Konstantinos G Moulakakis
Journal:  Int J Angiol       Date:  2018-01-22

9.  Vascular complications and special problems in vascular trauma.

Authors:  M J Martin; A J Perez-Alonso; J A Asensio
Journal:  Eur J Trauma Emerg Surg       Date:  2013-10-23       Impact factor: 3.693

10.  Safety and Efficacy of the Prostar XL Vascular Closing Device for Percutaneous Closure of Large Arterial Access Sites.

Authors:  Christoph Thomas; Volker Steger; Stefan Heller; Martin Heuschmid; Dominik Ketelsen; Claus D Claussen; Klaus Brechtel
Journal:  Radiol Res Pract       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.